Professor Manuel Freire-Garabal y Núñez has received the Medal of the Congress of the Republic of Peru, by nomination of the Foreign and Tourism Commission.
The recognition has been delivered by Congressman Alexander Lozano Inostroza and has been collected by Dr. Luis Suárez Hernández on behalf of Freire-Garabal, on the occasion of the pandemic.
Congress has granted him the recognition “conferred in the framework of the bicentennial of the independence of Peru. Merit to his permanent work of cooperation with the peoples of Peru and his unconditional support to spread our cultural and tourist wealth “as expressed in the certificate.
Likewise, the Tourist Magazine Dstinos Peru by the hand of Mónica Canales has recognized him as “Person of the Year” in the framework of the bicentennial for the multiple humanitarian and educational works of him with Dr. Luis Suárez.
In his last tour of Latin America, Dr. Luis Suárez has been received as a guest of honor in the countries of Peru, Ecuador and the Dominican Republic, among others. He has earned multiple accolades for his extensive humanitarian career. In Ecuador he received honors from the government, as well as the keys to the city of 5 cities such as Playa or Milagros, as well as being a distinguished guest of Guayaquil.
In the Galapagos Islands, he is considered a celebrity. That is why he has been recognized with the same distinctions as the actor Leonardo Di Caprio, which highlights his appointment as Environmental Ambassador of Galapagos as well as his adoption of a turtle by decree. Among other recognitions, he has also received the key to the city of San Cristóbal Island, Santa Cruz Island and Santa Isabela Island and the recognition of him as a distinguished guest in them.
Prof. Sir Manuel Freire-Garabal y Núñez is a lawyer and journalist. He is a professor, collaborator and advisor in different universities, particularly in the IVY League. He serves in diplomacy as an advisor to senior United Nations officials and as a member of the diplomatic staff of various governments. He has received high honors from the Russian Federation, the United States, or Peru.
He has made a notable contribution to education in the Middle East and Africa through Al-Khalifa Business School (AKBS) reaching more than 11,500 students worldwide and has awarded 300,000 scholarships through Governments and partner entities. Thanks to his humble efforts to create a better world, they have been recognized by various leading American media as “One of the fastest growing internationally accredited learning institutes of 2020.”
Recently Prof. Manuel Freire-Garabal has also been recognized by Lions International Club with two of its highest recognitions according to his contributions to the United States and the Bahamas in health and humanitarian aid, especially with the vaccination and food campaigns carried out. during the COVID-19 pandemic.
He is currently participating in several collaborative clinical studies on Obstructive Sleep Apnea (OSA) at Harvard Medical School Brigham and Women’s Hospital, Seep Division of Medicine. The collaborative research team includes Dr. Scott Sands as Principal Investigator, Dr. Reza Radmand, and Professor Manuel Freire-Garabal y Nunez.
Obstructive sleep apnea (OSA) is a common disorder caused by repeated blockage of the area at the back of the throat during sleep.
Overall, sleep-disordered breathing affects more than 1 billion people worldwide, and OSA is the most common type of sleep disorder. Many OSA patients eventually develop adverse sequelae such as cardiovascular disease, neurocognitive deficits, depression, and daytime sleepiness associated with motor vehicle accidents and poor quality of life. The most common treatment for OSA is continuous positive airway pressure (PAP) with the use of an air-generating device and a mask to flow air through the nose and mouth. This treatment modality is effective but is limited by very poor patient compliance and adherence. As a result, patients are turning to non-PAP alternatives, such as custom oral sleep aids.
Oral appliances work by advancing the lower jaw slightly forward during sleep and by opening the airways to prevent airflow obstruction. The therapy has increased adherence to PAP, with a favorable long-term therapeutic outcome for patients.